Effervescent naproxen tablets now available

Stirlescent is the first licensed effervescent formulation of naproxen. It is indicated in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute musculoskeletal disorders, dysmenorrhoea and acute gout in adults.

Further information
View Stirlescent drug record
Manufacturer: Stirling Anglian

The NHS list price of Stirlescent is £7.90 for a pack of 20 blackcurrant-flavoured 250mg tablets.

Stirlescent has been within NHS Scotland in patients unable to swallow naproxen tablets.

As with all NSAIDs, the lowest effective dose should be used for the shortest duration necessary to control symptoms.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from intelog

Drug shortages - live tracker

Drug shortages - live tracker

Added: Muse.
Use our constantly updated shortages...

New antibiotic guidance for diabetic foot infection

New antibiotic guidance for diabetic foot infection

NICE has updated its guidance on the prevention and...

Further drug shortages prompt advice to consider unlicensed alternatives

Further drug shortages prompt advice to consider unlicensed alternatives

Prescribers are being advised to prioritise supplies...

Vaping still safer than smoking, say health bosses after report of severe lung injury